$$$$$$$~BIG OTC DD PICKS AND LOW FLOAT MOVERS$$$$$$$

[$Pistol Pete$]

$VDRM ~ ViaDerma, Inc. due diligence report

$VDRM recent news/filings

## source: finance.yahoo.com

Sat, 06 Dec 2014 18:04:09 GMT ~ VIADERMA INC Financials


read full: http://finance.yahoo.com/q/is?s=vdrm
*********************************************************

Fri, 31 Oct 2014 16:27:00 GMT ~ These Small-Cap Marijuana Stocks are in Play Next Week

[Accesswire] - Coral Gables, FL / ACCESSWIRE / October 31, 2014 / ViaDerma, Inc. (OTCQB: VDRM) ecently released a revolutionary new wound care drug called TetraStem. TetraStem is a topical liquid tetracycline-based antibiotic ...

read full: http://finance.yahoo.com/news/small-cap-marijuana-stocks-play-162700926.html
*********************************************************

Thu, 30 Oct 2014 12:00:00 GMT ~ ViaDerma, Inc. Lead Product TetraStem Shown Effective in Fighting Staph Infections including MRSA

[PR Newswire] - LOS ANGELES, Oct. 30, 2014 /PRNewswire/ -- ViaDerma, Inc. (VDRM), a specialty pharmaceutical company devoted to bringing new products to market, has recently released a revolutionary new wound care drug called TetraStem. The drug is FDA registered as a first aid antibiotic to help prevent skin infection in minor cuts, scrapes, and burns, but has also shown to be effective in fighting methicillin-resistant Staphyloccus aureus (MRSA) infections. According to Mayo Clinic, Staph bacteria are normally found on the skin or in the nose of about one-third of the population. MRSA infection is caused by a strain of staph bacteria that's become resistant to the antibiotics commonly used to treat ordinary staph infections.

read full: http://finance.yahoo.com/news/viaderma-inc-lead-product-tetrastem-120000364.html
*********************************************************

Wed, 29 Oct 2014 19:26:00 GMT ~ ViaDerma, Inc. Announces Plans to Pursue Out-Licensing Partnerships in 2015

[PR Newswire] - LOS ANGELES, Oct. 29, 2014 /PRNewswire/ -- ViaDerma, Inc. (VDRM), a specialty pharmaceutical company devoted to bringing new products to market, is committed to pursuing out-licensing partnerships in 2015. ViaDerma has developed an innovative, patent-pending dual carrier transdermal delivery method, which allows for rapid mass transfer of pharmaceutical active ingredients to penetrate the skin and into the body to provide immediate localized therapy. The transdermal delivery method also overcomes microbial drug resistances, which the Company believes will prolong the viability of antibiotics for years to come. The company has potential to pair this technology with a wide variety of active ingredients to develop new antimicrobial drugs with pharmaceutical companies that license from ViaDerma.

read full: http://finance.yahoo.com/news/viaderma-inc-announces-plans-pursue-192600872.html
*********************************************************

Tue, 05 Aug 2014 13:36:00 GMT ~ ViaDerma, Inc. Announces Strategic Partnership With The Brewer Group

[PR Newswire] - MINNEAPOLIS, and BEVERLY HILLS, Calif., Aug. 5, 2014 /PRNewswire/ -- ViaDerma, Inc. (VDRM), a biotechnology licensing company committed to bringing new products quickly to the pharmaceutical industry through innovative research and development, and The Brewer Group, Inc. (TBG), a diversified global investment advisory firm, today announced a new strategic partnership. TBG will expand ViaDerma's business development and marketing efforts at home and abroad to grow interest in ViaDerma's patent-pending pharmaceutical delivery system, which allows for rapid transdermal transfer of active ingredients and immediate relief of symptoms. Pharmaceutical companies seeking more efficient methods for delivering their products to patients will have new access to solutions worldwide, as The Brewer Group, Inc. and ViaDerma, Inc. leverage TBG's vast network to pave the way for new strategic business alliances and expand the range of the breakthrough rapid delivery of nutrients and medicines using ViaDerma's technology.

read full: http://finance.yahoo.com/news/viaderma-inc-announces-strategic-partnership-133600244.html
*********************************************************

$VDRM charts

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com



big daily chart ## source: stockcharts.com



big weekly chart ## source: stockcharts.com


$VDRM company information

## source: otcmarkets.com

Link: http://www.otcmarkets.com/stock/VDRM/company-info
Ticker: $VDRM
OTC Market Place: OTC Pink No Information
CIK code: 0001435717
Company name: ViaDerma, Inc.
Incorporated In: NV, USA

Business Description: ViaDerma, Inc. is a pharmaceutical company committed to bringing new products to the pharmaceutical industry through innovative research and development. The Company manufactures and sells products in fields of medicine ranging from infectious diseases to stem-cell therapy. The Company?s products are normally applied topically using a patent-pending delivery system technology created by Dr. Phillips and Dr. Chris Ayo Otiko. Presently, the products are used within the OTC drug market, i.e. non-prescription. However, the Company believes the delivery system can be used for the prescription medication market as well not only for topical prescription medications but also to turn certain oral medications into topically based medications.In addition to the primary plan of developing and selling new products to the market, the Company is exploring the possibility of licensing the technology to other pharmaceutical companies.Less >>


$VDRM share structure

## source: otcmarkets.com

Market Value: $314,382 a/o Jun 26, 2015
Shares Outstanding: 73,112,116 a/o Sep 30, 2014
Float: 10,428,638 a/o Aug 13, 2014
Authorized Shares: 150,000,000 a/o Sep 30, 2014
Par Value: 0.001
$VDRM extra dd links

Company name: ViaDerma, Inc.
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/VDRM/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/VDRM/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=VDRM+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=VDRM+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=VDRM+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/VDRM/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/VDRM/news - http://finance.yahoo.com/q/h?s=VDRM+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/VDRM/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/VDRM/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/VDRM/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/VDRM/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/VDRM/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/VDRM/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/VDRM/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/VDRM/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=VDRM+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/VDRM
DTCC (dtcc.com): http://search2.dtcc.com/?q=ViaDerma%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=ViaDerma%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=ViaDerma%2C+Inc.&x=0&y=0

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/VDRM/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/VDRM
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/VDRM/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/VDRM/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/VDRM/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001435717&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/VDRM/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/VDRM/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/VDRM/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/VDRM/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=VDRM&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=VDRM
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/VDRM/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=VDRM+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=VDRM+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=VDRM
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=VDRM
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=VDRM+Cash+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/VDRM/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=VDRM+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/VDRM.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=VDRM
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/VDRM/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/VDRM/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/VDRM/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/VDRM/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/VDRM
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/VDRM
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/VDRM:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=VDRM
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=VDRM